GAIN Working Paper 28 : Developing Strategies To Commercialise Biofortified Crops And Foods

By:
Annette M Nyangaresi, Valerie M Friesen, Bonnie McClafferty, Charl van der Merwe, Daniel Haswell, Byron Reyes, Bho Mudyahoto, Mduduzi NN Mbuya
Global Alliance for Improved Nutrition (GAIN), HarvestPlus
Date:
2022

Biofortification of staple crops has the potential to contribute to reducing micronutrient deficiencies by increasing micronutrient intakes. In 2019, GAIN and HarvestPlus entered a partnership to lead the Commercialisation of Biofortified Crops (CBC) Programme, which aims to catalyse commercial markets for biofortified crops in six countries across Africa and Asia.

During the CBC programme inception phase, information on the value chains and their challenges and opportunities for commercialisation were collected for each country-crop combination through literature reviews and third party-led commercialisation assessments. This paper, summarises the processes undertaken to identify the potential opportunities and barriers for commercialisation and describe how the findings were used to develop commercialisation strategies for nine country-crop combinations.Common opportunities identified for commercialising biofortified crops and foods included: availability of competitive biofortified seed varieties to increase seed production, potential to strengthen seed production and distribution capacity through financial and/or technical support, opportunities to establish partnerships with processors and retailers and engage with consumers to increase demand for biofortified foods, and presence of (or potential for) an enabling policy environment to support the commercialisation of biofortified crops and foods. Conversely, common barriers identified included: poor communication of the value proposition of biofortified crops and foods, underdeveloped seed systems, lack of segregation of grains, and poor harmonisation of policies.

For each country-crop combination, a programme impact pathway was used to interpret and contextualise the findings, identify the most promising commercial pathway and its binding constraint, and develop a detailed commercialisation strategy to address it. The evidence review, generation, and interpretation activities enabled the development of nine context-specific commercialisation strategies. Evidence-based assessments linked to a programme impact pathway can strengthen programme design and increase potential for impact.

Download the Complete Working Paper 

The key messages contained in this paper are: 

• Programmes aimed at scaling up production and consumption of biofortified foods can benefit from systematic commercialisation assessments at inception to identify potential opportunities and barriers

• Understanding the opportunities for and barriers to commercialising biofortified crops and foods can ensure strategies are developed that leverage opportunities and unlock barriers.

• Collection of such data as part of an inception phase may be a lengthy process but is a necessary step to ensure programmes are evidence based and have high potential for impact.

 

Related Resources : 

GAIN Working Paper Series 29 - Using A Programme Impact Pathway To Design, Monitor, And Evaluate Interventions To Commercialise Biofortified Crops And Foods

GAIN discussion paper 11 : Commercialising public agricultural technologies and goods

This resource is for your information